Dutch look ahead to EU presidency role
This article was originally published in Clinica
With Ireland already halfway through its six-month presidency of the European Council, the next country taking the lead, the Netherlands, is taking steps to prepare its medical device programme. It met with the European Commission and the Irish representatives this week to discuss items that should be on the competent authorities medical devices meeting being held at the beginning of its presidency in Rotterdam on July 8-10. A key item will be assessing the likely status of the review of the Medical Devices Directive during the Dutch presidency.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.